---
schema_version: "secwatch.filing_event.v1"
accession: "0000059478-23-000282"
form_type: "8-K"
ticker: "LLY"
cik: "0000059478"
company_name: "ELI LILLY & Co"
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T01:16:51.702519+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lilly Q3 revenue up 37% to $9.5B; reported EPS loss $0.06 on $3.29 IPR&D charges, non-GAAP EPS $0.10

## Summary
- Revenue $9,498.6M (+37% YoY) driven by Mounjaro, Verzenio, and $1.42B from olanzapine rights sale.
- Reported net loss of $57.4M ($0.06 loss per share); non-GAAP net income $94.8M ($0.10 EPS).
- Acquired IPR&D charges of $3.29/share and olanzapine gain of $1.22/share impacted EPS.
- 2023 reported EPS guidance lowered to $5.95-$6.15; non-GAAP EPS to $6.50-$6.70.
- Completed acquisitions of DICE, Versanis, Emergence, Sigilon; agreed to buy POINT Biopharma.

## SEC filing metadata
- accession: 0000059478-23-000282
- form_type: 8-K
- ticker: LLY
- cik: 0000059478
- company_name: ELI LILLY & Co
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/59478/000005947823000282/0000059478-23-000282-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/59478/000005947823000282/lly-20231102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000059478-23-000282
- JSON: https://secwatch.observer/filing/0000059478-23-000282.json
- Plain text: https://secwatch.observer/filing/0000059478-23-000282.txt

## Key facts
- Earnings Releases
  ELI LILLY & Co reported the third quarter of 2023 results: revenue $9,498.6, net income $(57.4), EPS $(0.06).
  - Period: the third quarter of 2023
  - Revenue: $9,498.6
  - Net income: $(57.4)
  - EPS: $(0.06)
  - Result: reported results
  source text: Revenue $9,498.6 $6,941.6 37% Net income (loss) – Reported (57.4) 1,451.7 NM Earnings (loss) per share – Reported (0.06) 1.61 NM
  evidence_url: https://www.sec.gov/Archives/edgar/data/59478/000005947823000282/0000059478-23-000282-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.